Publication for BGN and COL11A1
| Species | Symbol | Function* | Entrez Gene ID* | Other ID | Gene coexpression |
CoexViewer |
|---|---|---|---|---|---|---|
| hsa | BGN | biglycan | 633 | [link] | ||
| hsa | COL11A1 | collagen type XI alpha 1 chain | 1301 |
| Pubmed ID | Priority | Text |
|---|---|---|
| 30723390 | 0.96 | COL11A1, MMP2, PXDN, BGN, COL5A1, COL8A1, and TGFB1I1 were associated with the patient's prognosis(P < 0.05). |
| 0.65 | BGN, TGFB1I1, AEBP1, CDH11, COL1A1, COL1A2, COL11A1, MMP2, PXDN, and THY1 was related to the poor prognosis of the disease. | |
| 29133944 | 0.96 | biglycan (BGN), COL11A1, COL11A2, and COL6A6 (highlighted in purple, segregating valves) (Fig. 2b). |
| 17411443 | 0.86 | BGN, POSTN, COL4A1, COL11A1, COL1A2 and COL5A2. |
| 0.61 | COL11A1, COL1A2, COL5A2, IGFBP3, FN1, ANXA2, BGN and PTGDS) and all 4 genes detected from the z-statistic as effect size (PTTG1, COL5A2, IGFBP3 and PTGDS) are associated with angiogenesis. | |
| 21931594 | 0.74 | COL11A1, COL7A1, COL10A1), biglycan, fibronectin, COMP, procollagen-lysine, 2-oxoglutarate 5-dioxygenase2 (PLOD2), and tissue inhibitor of matrix metalloproteinase 3 (TIMP3). |
| 19519926 | 0.71 | Col11a1, aggrecan, matrilin-3, or fibromodulin alone or together with biglycan, which lead to age-dependent cartilage degeneration similar to that in OA patients. |
| 21029365 | 0.69 | COL11A1 and COL18A1, cartilage oligomeric protein (COMP), biglycan (BGN), hyaluronan and proteoglycan link protein 1 (HAPLN1), fibronectin (FN), tenascin-C (TNC) and nidogen-1 (NID1) in particular (Table 1). |
| 28128526 | 0.64 | Col 11A1, Col VI), FN1, BGN, TGM2, and TUBB5 (Table 1). |
The preparation time of this page was 0.0 [sec].
